Redeye updates its estimates after Sleep Cycle’s Q4 2023 report, which came in slightly lower on sales and EBIT. However, when adjusting for an impairment charge,
Read more and download the Research Update.
Follow companies at Redeye to receive the latest equity research within Life Science and Technology.
This is a press release from Redeye - Research Powered Investment Banking. www.redeye.se/
© Modular Finance, source